Raloxifene Hydrochloride

Raloxifene is an estrogen agonist/antagonist indicated for:

  • Treatment and prevention of osteoporosis in postmenopausal women
  • Reduction in risk of invasive breast cancer in postmenopausal women with osteoporosis
  • Reduction in risk of invasive breast cancer in postmenopausal women at high risk for invasive breast cancer

Important Limitations: Raloxifene is not indicated for the treatment of invasive breast cancer, reduction of the risk of recurrence of breast cancer, or reduction of risk of noninvasive breast cancer

There are no products to list in this category.

Continue